company

NILS NORMANS FORSKNINGSFOND TIL HORMONLABORATORIETS FREMME

0424 OSLO

Return on Equity
−7,31 %
Current Ratio
1 505,27
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue897 000
Net Income−1 209 000
Total Assets16 558 000
Total Equity16 547 000
Income (NOK)2022
Revenue897 000
Expenditure2 106 000
Operating Profit−1 209 000
Financial Income0
Financial Costs0
Financial Balance0
Earnings Before Tax−1 209 000
Tax0
Net Income−1 209 000
Balance (NOK)2022
Total Fixed Assets0
Total Current Assets16 558 000
Total Assets16 558 000
Total Retained Equity1 868 000
Total Equity16 547 000
Total Long-Term Debt0
Total Current Debt11 000
Total Equity and Debt16 558 000
Cash flow (NOK)2022
Sales Income0
Other Income897 000
Revenue897 000
Cost of Goods Sold0
Salary Costs0
Depreciation0
Impairment0
Expenditure2 106 000
Operating Profit−1 209 000
Financial Income0
Financial Costs0
Financial Balance0
Dividends0
Net Income−1 209 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets0
Stock0
Total Investments16 418 000
Cash, Bank140 000
Total Current Assets16 558 000
Total Assets16 558 000
Total Equity16 547 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors0
Unpaid Taxes0
Dividends0
Other Current Debt11 000
Total Current Debt11 000
Total Equity and Debt16 558 000
Financial indicators2022
Return on Equity−7,31 %
Debt-to-Equity Ratio0
Operating Profit Margin−134,78 %
Current Ratio1 505,27
Quick Ratio1 505,27
Equity Ratio1
Gross Profit Margin100 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English